Back to Search
Start Over
Assessment of TNF-α inhibitors in airway involvement of relapsing polychondritis
- Source :
- Medicine, Medicine, Lippincott, Williams & Wilkins, 2019, 98 (44), pp.e17768. ⟨10.1097/MD.0000000000017768⟩, Medicine, 2019, 98 (44), pp.e17768. ⟨10.1097/MD.0000000000017768⟩
- Publication Year :
- 2019
- Publisher :
- HAL CCSD, 2019.
-
Abstract
- International audience; Relapsing polychondritis (RP) is a rare immune-mediated disease affecting cartilaginous structures. Respiratory tract manifestations are frequent and constitute a major cause of morbidity and mortality. The present review of the literature was designed to assess the efficacy of tumor necrosis factor alpha (TNF-a) inhibitors in respiratory tract involvement of RP. A MEDLINE literature search was performed from January 2000 to December 2016 to identify all studies and case reports of anti-TNF-a therapy in RP. Articles published in English or French concerning patients with respiratory tract involvement were eligible. Two authors (JB, FL) independently reviewed and extracted data concerning each patient and 2 personal cases were added. Treatment efficacy was assessed according to systemic and/or respiratory criteria. A total of 28 patients (mean age: 41.6 years; 16 females/12 males) were included in the final analysis. Anti-TNF-a therapy was associated with improved health status and respiratory symptoms in 67.8% and 60.1% of cases, respectively. These results suggest that TNF-a inhibitors could be considered for the treatment of respiratory tract involvement of RP. Abbreviations: CT = computed tomography, FDG/PET = fluorodeoxyglucose positron emission tomography, RP = relapsing polychondritis, TNF-a = tumor necrosis factor alpha.
- Subjects :
- [SDV]Life Sciences [q-bio]
relapsing polychondritis
[SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract
[SDV.IMM]Life Sciences [q-bio]/Immunology
[SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy
[SDV.IMM.IMM] Life Sciences [q-bio]/Immunology/Immunotherapy
TNF-a inhibitors
airways
[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract
ComputingMilieux_MISCELLANEOUS
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
TNF-α inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 00257974 and 15365964
- Database :
- OpenAIRE
- Journal :
- Medicine, Medicine, Lippincott, Williams & Wilkins, 2019, 98 (44), pp.e17768. ⟨10.1097/MD.0000000000017768⟩, Medicine, 2019, 98 (44), pp.e17768. ⟨10.1097/MD.0000000000017768⟩
- Accession number :
- edsair.dedup.wf.001..faa5445e6da823bbced5276bc477581e